#DYK Allergic asthma is primarily driven by abnormal T helper (Th2) cells, where interleukin receptors and STAT6, a crucial transcription factor, play central roles in inflammation and disease progression. A major hurdle in asthma treatment is the lack of biocompatible vectors for efficient siRNA delivery to target cells. Join AAPS tomorrow as Mahavir Bhupal Chougule, Ph.D., of Mercer University, presents a study using receptor-guided STAT6 siRNA-loaded gelatin #nanocarriers conjugated with a targeting peptide to selectively deliver siRNA to T cells.
All AAPS members receive access to numerous archived AAPS #webinars similar to this along with many other high-value benefits.
Learn more!
------------------------------
Stacey Axler
Community Manager
AAPS
Arlington VA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------
Original Message:
Sent: 04-07-2025 17:33
From: Mitra Mosharraf
Subject: Upcoming webinar: Actively Targeted Delivery of Transcription Factor siRNA-Loaded Polymeric Nanoparticles for Treating Chronic Asthma
Don't miss this exciting webinar on Actively Targeted Delivery of Transcription Factor siRNA-Loaded Polymeric Nanoparticles for Treating Chronic Asthma by Dr. Mahavir Chougule's on April 10th at noon ET. Register
See you!
------------------------------
Mitra Mosharraf, PhD
Chair, AAPS Nanotechnology
HTD Biosystems, CSO
[email protected]
Livermore, CA
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------